Latest Breaking News On - Establishment inspection report - Page 3 : comparemela.com

Natco Pharma gets EIR from USFDA on pharmacovigilance requirements

Natco Pharma gets EIR from USFDA on pharmacovigilance requirements
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

United statesNatco pharmaDrug administrationEstablishment inspection reportHyderabad based natcoUnited states food

Lupin receives Establishment Inspection Report from USFDA for its Aurangabad manufacturing facility

The inspection was conductedfrom March 6 to March 15, 2024. The U.S. FDA has determined that the inspection classification ofthe facility is Voluntary Action Indicated (VAI)

United statesNilesh guptaDrug administrationBoard of directors the companyLupin limited onVoluntary action indicatedLupin limitedEstablishment inspection reportUnited states foodManaging director

Small-cap Shares Fall Sharply - Monday Closing Report

On Monday, 925 stocks advanced, 3039 declined and 118 remained unchanged, with an advance decline ratio of 0.30 on the Bombay Stock Exchange (BSE), indicating negative closing of stocks in broader markets.

United statesKashipur uttarakhandGanesh benzoplastZydus lifesciencesBombay stock exchangeAdani green energyGmk centerSun pharmaceutical industries incGreen hydrogen derivativesAuthority of indiaLotus eye hospital and instituteRenewable energyWaterways authority of indiaBattery energy storage systemsMacrotech developersEnterpreneurship foundation mk group

Aurobindo Pharma Shares Down More Than 6% Amid US FDA Inspection

Aurobindo Pharma Shares Down More Than 6% Amid US FDA Inspection
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshNew delhiSanjeev sharmaAurobindo pharmaEugia pharma specialities ltdExchange board of india listing obligationDrug administrationAurobindo pharma limitedEugia pharma specialitiesExchange boardListing obligationDisclosure requirementChitkul villageEstablishment inspection reportVoluntary action indicated

Aurobindo Pharma shares down more than 6% amid US FDA inspection

Aurobindo Pharma shares fell more than 6 per cent on Thursday amid an inspection by the US Food and Drug Administration (FDA).Aurobindo Pharma shares were down 6.6 per cent at Rs 1,074 on the BSE. The company has a market cap of Rs 62,950 .

New delhiAndhra pradeshSanjeev sharmaAurobindo pharmaExchange board of india listing obligationEugia pharma specialities ltdDrug administrationAurobindo pharma limitedEugia pharma specialitiesExchange boardListing obligationDisclosure requirementChitkul villageEstablishment inspection reportVoluntary action indicated